Literature DB >> 33170142

Clinical and volumetric predictors of local control after robotic stereotactic radiosurgery for cerebral metastases: active systemic disease may affect local control in the brain.

Sławomir Blamek1, Magdalena Stankiewicz2, Bogusław Maciejewski1.   

Abstract

Background The aim of the study was to assess the association between physical and biological dose normalized to volume of the metastatic tumor as well as clinical factors with local control in patients with brain metastases who underwent robotic stereotactic radiosurgery. Patients and methods A cohort of 69 patients consecutively treated with robotic radiosurgery between 2011 and 2016 was analyzed. The patients were treated with either single fraction radiosurgery or hypofractionated regimens. Biologically effective dose (BED) was calculated assuming alpha/beta value = 10 and both physical dose and BED were normalized to the tumor volume to allow dose-volume effect evaluation. Moreover, clinical and treatment-related variables were evaluated to asses association with local control. Results A total of 133 tumors were irradiated and their volumes ranged between 0.001 and 46.99 cm3. Presence of extracranial progression was associated with worse local control whereas higher total dose, BED10 > 59 Gy and single metastasis predicted statistically significantly better local outcome. BED10/cm3 > 36 Gy, and BED2 > 60 Gy negatively affected local control in univariate analysis. In multivariate analysis performed on all these variables, presence of a single metastasis, BED10 > 59 Gy and extracranial progression retained their significance. Excluding a priori the BED2/ cm3 parameter resulted with a Cox model confirming significance of all remaining variables. Conclusions Hypofractionated treatment schemes have similar efficiency to single fraction treatment in terms of local control and the effect depends on BED irrespective of fractionation schedule. Effective control of extracranial sites of the disease is associated with higher probability of local control in the brain which in turn is consistently lower in patients with multiple lesions.

Keywords:  brain metastases; local control; radiobiology; radiosurgery

Year:  2020        PMID: 33170142     DOI: 10.2478/raon-2020-0065

Source DB:  PubMed          Journal:  Radiol Oncol        ISSN: 1318-2099            Impact factor:   2.991


  14 in total

1.  Hypofractionated stereotactic radiosurgery for pituitary metastases.

Authors:  Haemin Chon; KyoungJun Yoon; Do Hoon Kwon; Chang Jin Kim; Min-Seon Kim; Young Hyun Cho
Journal:  J Neurooncol       Date:  2017-01-09       Impact factor: 4.130

2.  Cyberknife stereotactic radiosurgery for the re-irradiation of brain lesions: a single-centre experience.

Authors:  Daniela Greto; Lorenzo Livi; Pierluigi Bonomo; Laura Masi; Beatrice Detti; Icro Meattini; Monica Mangoni; Raffaella Doro; Virginia Favuzza; Samantha Cipressi; Carmine Iermano; Ivano Bonucci; Mauro Loi; Gianpaolo Biti
Journal:  Radiol Med       Date:  2014-01-28       Impact factor: 3.469

3.  Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.

Authors:  E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-05-01       Impact factor: 7.038

4.  Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.

Authors:  Masaaki Yamamoto; Takuya Kawabe; Yasunori Sato; Yoshinori Higuchi; Tadashi Nariai; Shinya Watanabe; Hidetoshi Kasuya
Journal:  J Neurosurg       Date:  2014-12       Impact factor: 5.115

5.  Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.

Authors:  S W Lee; B A Fraass; L H Marsh; K Herbort; S S Gebarski; M K Martel; E H Radany; A S Lichter; H M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-01       Impact factor: 7.038

Review 6.  Prodding the Beast: Assessing the Impact of Treatment-Induced Metastasis.

Authors:  John M L Ebos
Journal:  Cancer Res       Date:  2015-07-30       Impact factor: 12.701

7.  Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.

Authors:  Maxime Loo; Yvan Pin; Alicia Thierry; Jean-Baptiste Clavier
Journal:  Clin Exp Metastasis       Date:  2020-03-17       Impact factor: 5.150

8.  A Dose-Volume Response Model for Brain Metastases Treated With Frameless Single-Fraction Robotic Radiosurgery: Seeking to Better Predict Response to Treatment.

Authors:  Mark J Amsbaugh; Mehran B Yusuf; Jeremy Gaskins; Anthony E Dragun; Neal Dunlap; Timothy Guan; Shiao Woo
Journal:  Technol Cancer Res Treat       Date:  2016-12-27

9.  Effect of dose fractionation on the enhancement by radiation or cyclophosphamide of artificial pulmonary metastases.

Authors:  J M Brown; G W Marsa
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

10.  A multi-center analysis of single-fraction versus hypofractionated stereotactic radiosurgery for the treatment of brain metastasis.

Authors:  Jill S Remick; Emily Kowalski; Rahul Khairnar; Kai Sun; Emily Morse; Hua-Ren R Cherng; Yannick Poirier; Narottam Lamichhane; Stewart J Becker; Shifeng Chen; Akshar N Patel; Young Kwok; Elizabeth Nichols; Pranshu Mohindra; Graeme F Woodworth; William F Regine; Mark V Mishra
Journal:  Radiat Oncol       Date:  2020-05-28       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.